Are Investing Seminars Worth It? As the old saying

New Post Public Reply Private Reply Replies (0) Message Board
NITE

Are Investing Seminars Worth It?

As the old saying goes, free advice is worth every penny you pay for it. Contrary to this ancient witticism, in some cases this advice could be very valuable. It depends on the source of the advice and what the adviser wants from those being advised. TUTORIAL: Investing 101 In the wake of the recent financial crisis, a virtual deluge of investment advice, packaged as investment seminars, has been offered free to the public in mailed letters, brochures and flyers, and in other forms of advertising and promotions. The recipient of these marketing messages justifiably wonders: Which among the many seminars offered would be beneficial? Here's how to answer that question.

Investment seminars may be broadly classified in two varieties:

•The seminar with something for sale.

•The seminar with no specific investment for sale.

The most common seminar is the first variety. These something-specific-for-sale seminars are offered by an individual, company, or institution such as a bank, insurance company or brokerage firm. While they do offer investment information, the seminars are designed principally to sell products and or services to the attendees. For every sale made, the seller receives a commission. So keep in mind that while these seminars impart information, they are also sales pitches. (For related reading, see The Sales Commission Dilemma.)

Most Frequently Sold Products/Services
Annuities, sold by financial planners and advisers, insurance companies, banks and brokers. Annuities generally provide the buyer with a lifetime return (with certain exceptions, spelled out in the contract) on a lump sum investment. Bonds of many kinds (i.e. debt, meaning contractual obligations to pay a certain rate of interest on a principal amount over a specified period of time). Stocks and balanced portfolios of stocks. Many seminars will offer a free portfolio analysis - meaning they'll look at all your investments and advise you on what to sell and what to buy for better returns, with relative safety and perhaps a small percentage allocated to a higher-risk, higher-return investment on your investments. As usual, the adviser-seller receives a commission on all sales. (For related reading, see What Is A Registered Investment Advisor?)

Specific targeted investment advice for retirement, for accumulating enough money for a college education for children or grandchildren, and for setting up trusts, among other investments and investment services offered. Brokers and brokerage firms often conduct seminars on trading stocks, stock options, commodities, and foreign currency. These can be high risk speculations for inexperienced investors and special caution is advised before trading in these often volatile markets.

Finally, seminars which offer information about esoteric investments which may yield high returns, should be regarded with a prudent skepticism. Sales pitches may hype certainemerging markets, foreign bonds, private equity firms, copper mines in Africa, derivatives of various types, and similar investment vehicles, suggesting that in best-case scenarios, the returns will be high. These may turn out to be successful investments, but pending regulatory oversight, certified audits and more transparency about the investment, investors are urged to be wary. (For more on emerging markets, see What Is An Emerging Market Economy.)

No Specific-Investments For Sale Seminars
Seminars which offer nothing for sale and are strictly informational or educational may provide the most benefits to attendees. Because nothing is for sale, the information provided is not skewed toward the usual biases which favor certain investments over others of roughly equal returns and safety.

Often, these seminars are given by independent financial advisers, or by authors of books on investments, media columnists or commentators, newsletter publishers, Website writers and other speakers with no specific investment to sell. But the financial advisers want to sell their expert advice, and may invite seminar attendees to make an appointment for a personal one-on-one consultation to discuss their investment goals and how to achieve them. Most likely at that meeting the adviser will try to sell fee-based and or performance-based services.

The writers and publishers who conduct investment seminars will probably try to sell their books, newsletters, Web subscriptions and other forms of information to the attendees.

Here's What to Do and Not to Do at Both Types of Seminars:
If you don't understand something, ask questions. If it's too complicated, ask to see it in writing. If you still don't understand the investment and how it works, steer clear. Ask to see the credentials of anyone purporting to be a certified financial planner. Ask for references. Maintain a high level of skepticism, especially when no-risk, high-return investments are touted. Keep in mind, the higher the projected return, the higher the risk, and in some cases, you can lose all the money you invest. Get a second opinion from an outside, disinterested source if you're considering an investment. Don't be rushed into buying something on the spot because the sales person says the markets are moving quickly and if you don't buy now you'll miss the profits.

If you do invest, experts say don't allocate more than 4% of your total portfolio to any one investment. That way, if the investment produces a loss, you won't be hurt too badly. (Learn how to weed out those who are just out to make a quick buck. For more, see Find The Right Financial Advisor.)


The Bottom Line
Investment seminars can be worth your time, but keep in mind that there's usually something for sale at most of them. Nevertheless, like your daily newspaper or favorite magazines or informational website, along with the advertisements of goods and services for sale, there's plenty of useful information and newsworthy stories. The same holds true for most investment seminars.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Planning Your Pergola: DIY Backyard Transformation

Updated Category News Views 21

Blueprint for a Backyard Upgrade Transforming a backyard isn't just about nailing down the aesthetics with a motorized pergola. The real magic is in thoughtful planning—right from the get-go. Whether you've got your sights set on the sleek FlexPatio motorized pergola kits or another setup, it all begins with a mental blueprint before a single speck of dirt is disturbed....

Continue Reading
Differentia Bio's AI: Transforming Drug Development Dynamics

Updated Category News Views 0

The Future of Drug Development: AI's New Role When it comes to pharmaceutical R&D, Some outfits are playing pin the tail on the donkey, but Differentia Bio over here is sharpening the pin with some futuristic gadgetry. Yep, they're jazzing up the game with AI-powered digital twins, building lifelike disease environments that predict therapeutic outcomes with precision...

Continue Reading
IntelliGenome Partners with NL Diagnóstica for TB Battle

Updated Category News Views 133

Breaking New Ground in Tuberculosis Detection When IntelliGenome, a Houston-based developer of CRISPR-based diagnostic tech, teams up with São Paulo's veteran player NL Diagnóstica, you know they're onto something game-changing. This partnership is all about taking the fight against tuberculosis in Brazil to new heights with their CRISPR-Dx™ diagnostic platform. Not...

Continue Reading
Cymat Explores Sc-Al Alloy JV: Critical Step Forward

Updated Category News Views 96

Scandium-Aluminum Alloy: A Game Changer? A joint venture announcement has investors buzzing, as Cymat Technologies Ltd. is gearing up for a game-changing push into the scandium-aluminum (Sc-Al) alloy space. Now, don't shrug this off as another run-of-the-mill alliance—there's meat on these bones, and it's worth a close look. The key takeaway is that Cymat's venture with...

Continue Reading
HIQILI's Organic Lavender Oil: Everyday Tranquility Unleashed

Updated Category News Views 0

Lavender: More Than Just a Bedtime Buddy Busting in from Jersey City, HIQILI’s thrown another organic punch into the wellness ring with their new lavender essential oil. But don’t get it twisted, this isn’t just for knocking you out at night. Think daytime pal—ready to hold your hand through any storm your calendar drums up. Traditional Aromas for Modern Madness...

Continue Reading
Envision's Green Ammonia Powers Game-Changing Shipping Milestone

Updated Category News Views 52

Envision's Big Bet on Green Ammonia It's a day to talk about paradigms shifting on the high seas. Envision, a heavy hitter in the green tech arena, just fueled the very first Very Large Ammonia Carrier (VLAC) with their certified green ammonia. Now, that's not just a milestone, it’s like finding a four-leaf clover in the world of maritime decarbonization—a tough nut...

Continue Reading
Texas A&M, Natura Tackle Nuclear Waste Recycling

Updated Category News Views 96

Ambitious Nuclear Fuel Recycling Underway Talk about turning trash into treasure. Natura Resources has teamed up with Texas A&M in a bold project aiming to recycle nuclear waste into usable fuel for new reactors. They've got federal backing to the tune of $5.4 million, courtesy of the U.S. Department of Energy. This effort to harness old nuclear waste has the potential to...

Continue Reading
Dodge Roars Back to NASCAR, Revving Up Stock Gains

Updated Category News Views 79

When Dodge decides to hit the track running, they mean it. They're cranking the engines and returning to the NASCAR Cup Series after years in the shadows. This isn't just about going fast; it's about redefining speed on the stock car circuit and maybe even the market tickers. Revving an Old Engine for a New Race Let's get this out there: Dodge pulling a U-turn back into...

Continue Reading
EClinCloud Targets Better FDA Compliance with AI Boost

Updated Category News Views 16

FDA Citations Under the Microscope Here we are, wading through another layer of clinical research nitty-gritty, and it's bringing clinical processes under a sharper lens. EClinCloud just dropped a hefty analysis on 1,715 FDA Bioresearch Monitoring citations. Turns out, protocol compliance, informed consent, and case histories chew up 46.2% of these citations. Sounds like...

Continue Reading
Montefiore Einstein Celebrates 25 Years of Child Care

Updated Category News Views 51

A Quarter Century of Care and Breakthroughs If anyone thinks a hospital anniversary isn't important, they've never stepped inside the Children's Hospital at Montefiore Einstein (CHAM) in the Bronx. Celebrating 25 years this October, CHAM has become a lifeline for more than 300,000 children, not just locally, but nationally, known for its ground-breaking clinical care and...

Continue Reading

Top 5 Most Recently Viewed Articles

Velo3D Partners with Ohio Ordnance for 3D Printing Advancements

Updated Category News Views 172

Strengthening Defense Through Innovative Collaboration In the evolving landscape of military manufacturing, Velo3D, Inc. (OTCQX: VLDX) has recently embarked on an exciting new venture. They have formed a strategic partnership with Ohio Ordnance Works, Inc. (OOW) aimed at enhancing the capabilities of military weapons through advanced 3D printing technology. Enhancing...

Continue Reading
Discovering Intentional Living Through Mike Greene's New Book

Updated Category News Views 142

Unlocking Intentional Living with "60 Second Success" Coach and author Mike Greene provides practical insights to help readers align decisions with their values. Mike Greene, a renowned leadership coach and founder of IntegrityWorks Coaching, has launched an engaging new book titled "60 Second Success: Transform Your Life One Thoughtful Minute at a Time." This book...

Continue Reading
Investors Should Act Now: Dow Inc. Faces Class Action Deadline

Updated Category News Views 184

Investors Urged to Participate in Class Action Recent developments regarding Dow Inc. are drawing attention. Investors who suffered financial losses are encouraged to take action amidst news of a class action lawsuit. The window to file a lead plaintiff motion is fast approaching, with a deadline set for later this month. Understanding the Background A closer look at the...

Continue Reading
Gap Inc. Delivers Strong Q3 Results and Uplifts Expectations

Updated Category News Views 219

Gap Inc. Reports Strong Third Quarter Results Gap Inc. has announced a successful third quarter, reporting a net sales increase of 2% compared to the previous year, with comparable sales rising 1%. The company has achieved a remarkable operating margin of 9.3%, reflecting an improvement of 270 basis points from last year. These results demonstrate significant market share...

Continue Reading
Mitsubishi Electric Introduces High-Performance HVIGBT Modules

Updated Category News Views 246

Mitsubishi Electric to Launch New S1-Series HVIGBT Modules Mitsubishi Electric Corporation (TOKYO: 6503) has announced its plans to ship samples of two cutting-edge S1-Series High Voltage Insulated Gate Bipolar Transistor (HVIGBT) modules. These modules, rated at 1.7kV, are specifically engineered for large industrial applications including railcars and DC power...

Continue Reading